- Press Release: LGC Clinical Diagnostics, AccuGenomics Partner to Develop NGS Quality Control Materials (Oct 8th, 2024)
- AccuGenomics is the clear choice for improved accuracy in NGS assays (August 25th, 2021)
- Grant award from a USAF-SBIR Grant (July 27th, 2021)
- Grant award from NIIMBL (July 27th, 2021)
- AccuGenomics joins the FNIH Biomarkers Consortium focused on Measurable residual disease in acute myeloid leukemia (MRD in AML) (June 1st, 2020)
